Increased survival time in mice vaccinated with a branched lysine multiple antigenic peptide containing B- and T-cell epitopes from T. gondii antigens.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Vaccine

• Publication date

  2011-11-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2011.09.016PMID 21939715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis of Highly Immunogenic Multiple Antigenic Peptides for Epitopes of Viral Antigen to Use in ELISA

  2009cited by this paper
• Screening and identification of novel B cell epitopes in human heparanase and their anti-invasion property for hepatocellular carcinoma

  2009cited by this paper
• Multi-epitope DNA vaccine linked to the A2/B subunit of cholera toxin protect mice against Toxoplasma gondii.

  2008cited by this paper
• Immunisation with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes in saline suppresses rodent fertility.

  2008cited by this paper
• Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice.

  2008cited by this paper
• GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccine.

  2007cited by this paper
• Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.

  2007cited by this paper
• Multiple Antigenic Peptides as Vaccine Platform for the Induction of Humoral Responses Against Dengue-2 Virus

  2007cited by this paper
• Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model.

  2006cited by this paper
• Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice.

  2005cited by this paper
• Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model

  2005cited by this paper
• Synthesis of glycoconjugate vaccines for Candida albicans using novel linker methodology.

  2005cited by this paper
• Vaccination protects B cell-deficient mice against an oral challenge with mildly virulent Toxoplasma gondii.

  2004cited by this paper
• Differential antibody responses to Plasmodium falciparum-derived B-cell epitopes induced by diepitope multiple antigen peptides (MAP) containing different T-cell epitopes.

  2004cited by this paper
• Multiepitope Trojan Antigen Peptide Vaccines for the Induction of Antitumor CTL and Th Immune Responses1

  2004cited by this paper
• Adjuvant effect of dendritic cells transduced with recombinant vaccinia virus expressing HPV16-E7 is inhibited by co-expression of IL12.

  2004cited by this paper
• p47 GTPases: regulators of immunity to intracellular pathogens

  2004cited by this paper
• Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice.

  2003cited by this paper
• Development of a vaccine for toxoplasmosis: current status.

  2003cited by this paper
• Immune responses against excreted/secreted antigens of Toxoplasma gondii tachyzoites in the murine model.

  2003cited by this paper
• Deficient Humoral Responses Underlie Susceptibility to Toxoplasma gondii in CD4-Deficient Mice

  2002cited by this paper
• 200 Gy sterilised Toxoplasma gondii tachyzoites maintain metabolic functions and mammalian cell invasion, eliciting cellular immunity and cytokine response similar to natural infection in mice.

  2002cited by this paper
• Anti-SAG1 peptide antibodies inhibit the penetration of Toxoplasma gondii tachyzoites into enterocyte cell lines

  2001cited by this paper
• Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines.

  2001cited by this paper
• Congenital Toxoplasmosis: A Review

  2001cited by this paper
• Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene.

  2000cited by this paper
• Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase.

  2000cited by this paper
• Interleukin-12 (IL-12) Enhancement of the Cellular Immune Response against Human Immunodeficiency Virus Type 1 Env Antigen in a DNA Prime/Vaccinia Virus Boost Vaccine Regimen Is Time and Dose Dependent: Suppressive Effects of IL-12 Boost Are Mediated by Nitric Oxide

  2000cited by this paper
• Decreased Resistance of B Cell-Deficient Mice to Infection with Toxoplasma gondii Despite Unimpaired Expression of IFN-γ, TNF-α, and Inducible Nitric Oxide Synthase1

  2000cited by this paper
• DNA Vaccination with Genes EncodingToxoplasma gondii Antigens GRA1, GRA7, and ROP2 Induces Partially Protective Immunity against Lethal Challenge in Mice

  2000cited by this paper
• Inhibitory activity of anti-interleukin-4 and anti-interleukin-10 antibodies on Toxoplasma gondii proliferation in mouse peritoneal macrophages cocultured with splenocytes from infected mice

  2000cited by this paper
• B Cells Are Essential for Vaccination-Induced Resistance to Virulent Toxoplasma gondii

  2000cited by this paper
• A peptide construct containing B-cell and T-cell epitopes from the foot-and-mouth disease viral VP1 protein induces efficient antiviral protection.

  1999cited by this paper
• Complete Protection against Lethal Toxoplasma gondii Infection in Mice Immunized with a Plasmid Encoding theSAG1 Gene

  1999cited by this paper
• Interleukin-12: a cytokine at the interface of inflammation and immunity.

  1998cited by this paper
• Protective Effect of Vaccination with a Combination of Recombinant Surface Antigen 1 and Interleukin-12 against Toxoplasmosis in Mice

  1998cited by this paper
• Interferon‐γ‐activated primary enterocytes inhibit Toxoplasma gondii replication: a role for intracellular iron

  1998cited by this paper
• Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice.

  1998cited by this paper
• Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection

  1998cited by this paper
• IL-4 is protective against development of toxoplasmic encephalitis.

  1996cited by this paper
• Immunological control of Toxoplasma gondii and appropriate vaccine design.

  1996cited by this paper
• Different roles for interleukin-4 during the course of Toxoplasma gondii infection

  1996cited by this paper
• The role of natural killer cells in host-parasite interactions.

  1995cited by this paper
• Fine specificity of immune responses to epitopic sequences in synthetic peptides containing B and T epitopes from the conserved Plasmodium falciparum blood-stage antigens.

  1995cited by this paper
• Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii.

  1994cited by this paper
• Interleukin-12 enhances murine survival against acute toxoplasmosis

  1994cited by this paper
• Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation.

  1993cited by this paper
• A chemically defined synthetic vaccine model for HIV-1.

  1992cited by this paper
• Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus.

  1991cited by this paper
• Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes.

  1991cited by this paper
• Lack of H‐2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide

  1991cited by this paper
• Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes.

  1989cited by this paper
• Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.

  1988cited by this paper
• Characterization of an Indoleamine 2,3-Dioxygenase Induced by Gamma-Interferon in Cultured Human Fibroblasts

  1986cited by this paper
• Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii.

  1985cited by this paper
• Detection of circulating antigen in acute experimental infections with Toxoplasma gondii.

  1975cited by this paper
• Solid phase peptide synthesis. I. the synthesis of a tetrapeptide

  1963cited by this paper

• Toxoplasma gondii (GRA10): A Closer Glance Into Immunogenic and Biochemical Characteristics Using In Silico Approach

  2025cites this paper
• Evaluation of the therapeutic efficacy of albendazole and nitazoxanide loaded chitosan nanoparticles against experimental echinococcosis

  2025cites this paper
• Co-delivery of spiramycin and curcumin nanoemulsions for treating acute (RH strain) and chronic (Tehran strain) toxoplasmosis in BALB/c mice

  2025cites this paper
• Evaluation of the immunoprotective power of a multiple antigenic peptide against Aah II toxin of Androctonus australis hector scorpion

  2024cites this paper
• Biogenic selenium nanoparticles: trace element with promising anti-toxoplasma effect

  2023cites this paper
• In Silico Vaccine Design and Expression of the Multi-Component Protein Candidate against the Toxoplasma gondii Parasite from MIC13, GRA1, and SAG1 Antigens

  2023cites this paper
• Enhancement of immune responses by vaccine potential of three antigens, including ROP18, MIC4, and SAG1 against acute toxoplasmosis in mice.

  2022cites this paper
• The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis

  2022cites this paper
• Heat Shock Proteins 90 kDa: Immunomodulators and Adjuvants in Vaccine Design Against Infectious Diseases

  2021cites this paper
• Immuno-Efficacy of Multi-Epitope Chimeric Peptides Against Foot and Mouth Disease Virus: Potential Vaccine Candidates for Newly Emerged Serotype O and A

  2021cites this paper
• Immunogenicity of in-silico designed multi-epitope DNA vaccine encoding SAG1, SAG3 and SAG5 of Toxoplasma gondii adjuvanted with CpG-ODN against acute toxoplasmosis in BALB/c mice.

  2021cites this paper
• Enhancing Immune Responses to a DNA Vaccine Encoding Toxoplasma gondii GRA7 Using Calcium Phosphate Nanoparticles as an Adjuvant

  2021cites this paper
• Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50 V and determination of its protective efficacy against acute toxoplasmosis

  2020cites this paper
• Construction of A Synthetic Gene Encoding the Multi-Epitope of Toxoplasma gondii and Demonstration of the Relevant Recombinant Protein Production: A Vaccine Candidate

  2020cites this paper
• Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: A systematic review.

  2020cites this paper
• Design of an Epitope-Based Vaccine Ensemble for Animal Trypanosomiasis by Computational Methods

  2020cites this paper
• Epitope-based vaccine as a universal vaccination strategy against Toxoplasma gondii infection: A mini-review

  2019cites this paper
• Candidate antigenic epitopes for vaccination and diagnosis strategies of Toxoplasma gondii infection: A review.

  2019cites this paper
• A systematic review of Toxoplasma gondii antigens to find the best vaccine candidates for immunization.

  2019cites this paper
• In silico analysis and expression of a novel chimeric antigen as a vaccine candidate against Toxoplasma gondii.

  2019cites this paper
• Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.

  2019cites this paper
• Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses

  2019cites this paper
• Structural predication and antigenic analysis of Toxoplasma gondii ROP20

  2018cites this paper
• Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection.

  2018cites this paper
• Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice

  2017cites this paper
• Structuraland antigenic analysis of a new Rhoptry Pseudokinase Gene (ROP54) in Toxoplasma gondii

  2017cites this paper
• Identifying Novel B Cell Epitopes within Toxoplasma gondii GRA6

  2016cites this paper
• Experimental ovine toxoplasmosis: influence of the gestational stage on the clinical course, lesion development and parasite distribution

  2016cites this paper
• Review on the identification and role of Toxoplasma gondii antigenic epitopes

  2016cites this paper
• 675-688 He SY.pmd

  2016cites this paper
• Research advances in microneme protein 3 of Toxoplasma gondii

  2015cites this paper
• Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.

  2015cites this paper
• Protective immunity induced by peptides of AMA1, RON2 and RON4 containing T-and B-cell epitopes via an intranasal route against toxoplasmosis in mice

  2015cites this paper
• A Multiple Antigenic Peptide Mimicking Peptidoglycan Induced T Cell Responses to Protect Mice from Systemic Infection with Staphylococcus aureus

  2015cites this paper
• Research advances in microneme protein 3

  2015cites this paper
• Recent Advances in Toxoplasma gondii Immunotherapeutics

  2014cites this paper
• Excretory-secretory antigens: a suitable candidate for immunization against ocular toxoplasmosis in a murine model.

  2014cites this paper
• Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii

  2014cites this paper
• Analyzing and identifying novel B cell epitopes within Toxoplasma gondii GRA4

  2014cites this paper
• Vaccines against Toxoplasma gondii: new developments and perspectives

  2013cites this paper
• A novel strategy for classifying the output from an in silico vaccine discovery pipeline for eukaryotic pathogens using machine learning algorithms

  2013cites this paper
• DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c mice

  2013cites this paper
• Immunization with excreted–secreted antigens reduces tissue cyst formation in pigs

  2013cites this paper
• Screening and identification of novel B cell epitopes of Toxoplasma gondii SAG1

  2013cites this paper
• Identification of novel B cell epitopes within Toxoplasma gondii GRA1.

  2013cites this paper